570 likes | 3.39k Views
Objectives. Define Mallory Weiss Tear (MWT)Discuss the pathopysiologyHow do they present?Discuss management. Intro. upper GI bleeding 2? to longitudinal mucosal lacerations/tears near or at GE junction or gastric cardia ? transmuraloriginal description by Kenneth Mallory and Soma Weiss in 1929 involved patients with persistent retching and vomiting following an alcoholic binge .
E N D
1. Mallory Weiss Tear Ruth O’Carroll R4
July 7, 2006
3. Intro upper GI bleeding 2? to longitudinal mucosal lacerations/tears near or at GE junction or gastric cardia
? transmural
original description by Kenneth Mallory and Soma Weiss in 1929
involved patients with persistent retching and vomiting following an alcoholic binge
Can extend up the distal esophagusCan extend up the distal esophagus
5. Pathophysiology rapid rise in intragastric pressure
ppting factors
retching
vomiting
? transmural pressure gradient across hiatal hernia
negative intrathoracic pressure and positive intragastric pressure leads to distortion of gastric cardia
resulting in gastric or esophageal tear
shearing forces are > enough
longitudinal laceration eventually occurs
120-160mmHg
tear is more likely to involve lesser curvature of gastric cardia
relatively immobile
violent prolapse/intussusception of stomach into esophagus
forceful retching at endoscopy
large, rapidly occurring, and transient transmural pressure gradient across the region of GE junction
Acute distension of nondistensible lower esophagus can also produce a linear tear in this region.
In cadavers intragastric pressure >15ommHg produced mucosal lacerations
large, rapidly occurring, and transient transmural pressure gradient across the region of GE junction
Acute distension of nondistensible lower esophagus can also produce a linear tear in this region.
In cadavers intragastric pressure >15ommHg produced mucosal lacerations
6. Stats 1-15% UGI bleeds in the US
? racial predilection
?:? 2-4:1
Age - 40s/50s
age range is quite wide
7. Presentation Episode of hematemesis following a bout of retching or vomiting
Hematemesis is present in 85% of pts
Less common presenting syx
Melena
Hematochezia
Syncope
Abdominal pain
Excessive EtOH use reported in 40-75%
Aspirin use in up to 30%
Attempt to identify a precipitating factor for the MWT
although this presentation may be less common than previously thought. Graham and Schwartz found that a typical history was obtained in only about 30% of patients. In a study by Harris and DiPalma, hematemesis on first emesis was reported in 50% of patients.
although this presentation may be less common than previously thought. Graham and Schwartz found that a typical history was obtained in only about 30% of patients. In a study by Harris and DiPalma, hematemesis on first emesis was reported in 50% of patients.
8. Ppting factors Presence of hiatal hernia
35-100%
Retching
Vomiting
Straining
Hiccuping
Transesophageal echo
Esophageal dilatation
Coughing
Primal scream therapy
Blunt abdominal trauma
Child birth
Bowel prep with PEG lavage
CPR
EtOH use
>90% pt
Cirrhosis/portal HTN
? M&M
9. Physical exam findings relate to rate + degree of blood loss
Tachycardia
Hypotension
Orthostatic changes
Overt shock
10. Initial Management ABCs
then
2 large bore IVs
Monitor U/O
Blood work
Gastric lavage/NG tube
11. Lab Studies CBC
Lytes
Coags
Group/screen +/-crossmatch
ECG +/- cardiac enzymes
12. Management Early endoscopy
Within 24h
13. Endoscopy ID active bleeding, adherent clot, or fibrin crust over mucosal split within/near GE jxn
split
~ 2-3cm in length
few mm in width
>80% pts present with single tear
usual location of the tear (50-80% pt)
just below GE jxn on lesser curve of stomach
b/w 2 + 6 o'clock on endoscopic viewing with pt in left lateral decubitus position
9-18% extend to esophagus
14. Endoscopy cont. Important to ID other cause
80% pt have coexisting lesion
Gastric, DU
Esophagitis
Varices
Duodenitis
15. To treat, or not to treat? actively bleeding MWTs are treated
arterial spurting
streaming from focal point
diffuse oozing
nonbleeding visible vessel or adherent clot ? necessarily require tx
Treat if
rebleeding episodes from same lesion
associated with a coagulopathy
clean, fibrinous base or with flat, pigmented spots ? treated
risk of rebleeding is minimal
16. Endoscopic tx Choice depends on endoscopist's familiarity with particular technique + equipment availability
Heater probe
Epinephrine (1:10,000-1:20,000)
Sclerosants - ? advised
Argon Plasma coagulator
Endoscopic band ligation/hemoclipping
? use balloon tamponade
Selective vasopressin infusion/embolization of left gastric artery
17. Higuchi et al 2006 prospective study August ‘98 - June ‘05
37 pts with MWT who had active bleeding, exposed vessels, or both
treated using endoscopic band ligation
successful in 36/37 cases
f/u 1-24 mo
? recurrent bleeding, perforation, or other complications
1 mortality - severe liver failure + DIC
18. Park et al 2004 Prospective trial 34 consecutive pts actively bleeding MWT
randomly assigned to undergo endoscopic band ligation or endoscopic injections of a 1:10,000 solution of epinephrine
# of elastic bands applied was 1-2
mean volume of epinephrine injected was 18.0 mL
Primary hemostasis
band ligation group 17/17
epinephrine injection group 16/17
? recurrence of bleeding or major complication in either group ? significant difference between the groups with respect to age, gender, alcohol ingestion, presenting symptoms, Hb level, shock, comorbid diseases, coagulopathy, tear location, blood transfusion, or duration of hospitalization.? significant difference between the groups with respect to age, gender, alcohol ingestion, presenting symptoms, Hb level, shock, comorbid diseases, coagulopathy, tear location, blood transfusion, or duration of hospitalization.
19. Course Most have stopped bleeding at time of endoscopy
80-90% heal uneventfully within 48h
5-35% require some form of intervention
mostly endoscopic
Supportive care
volume +/- blood replacement
acid suppression
antiemetic drug therapy
Surgical Care
oversewing of tear is reserved for MWT refractory to endoscopic therapy or angiotherapy
20. Kim et al 2005 Retropsective review Jan’99 – Dec’03
159 pt
22 ?, 137 ?
mean age 48.1yo
Recurrent bleeding in 17 patients (10.7%)
? frequency for the presence of shock at initial manifestation
(OR 3.71, 95% CI 1.07-14.90)
combined liver cirrhosis
endoscopic findings of active bleeding
(OR 9.89, 95% CI 1.88-51.98)
? Hb and platelet count
? transfusions
? epinephrine-mixed fluid injections
longer hospital stay
21. Vasopressin Some benefit in pt with continued bleeding
Continuous infusion over 48h
Bolus 20U then 0.4-0.6U/min
No prospective studies
22. Surgery 3-9% cases
Continued bleeding despite endoscopy + correction of coags
Threshhold 6U RBC
Method ? No prospective dataNo prospective data
23. Sx tx Upper midline incision
Longitudinal ant. gastrotomy
Examine gastric mucosa
+/- mobilize GE jxn
Try 2 NG tubes
Large foley+/-sigmoidoscope
Oversew with absorbable suture
Distal?proximal
24. Summary Dx from history
Early endoscopy
Most heal without intervention
Numerous endoscopic modalities to control bleeding
If continued bleeding/shocky ? OR
25. References Cameron, Current Surgical Therapy.
Higuchi, N., et al. (2006) Endoscopic band ligation therapy for upper gastrointestinal bleeding related to Mallory-Weiss syndrome. Surg Endosc. May 15.
Kim, J., et al. (2005) Predictive factors of recurrent bleeding in Mallory-Weiss syndrome. Korean J Gastroenterol. 46(6):447-54.
Park, C., et al. (2004) A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc. 60(1):22-7.
www.emedicine.com